A study to evaluate the use of mobile-phone based patient support in patients diagnosed with Myocardial Infarction - SUPPORT
Study identifier:ME-CV-1301
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A study to evaluate the use of mobile-phone based patient support in patients diagnosed with Myocardial Infarction - SUPPORT
Medical condition
myocardial infarction
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
174
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Jun 2013
Primary Completion Date: 01 Dec 2014
Study Completion Date: 01 Dec 2014
Study design
Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Other
Verification:
Verified 01 Dec 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: Active group The software application used on the patients’ smart phones in the active group, will contain both the e-diary and the mobile-phone based patient support. Patients will receive feedback by the mobile-phone based support not only on the data they enter into the mobile-phone based patient support but also on their reported daily ticagrelor use. | Device: Mobile-phone based patient support The mobile-phone based patient support (investigational medical device) is a stand-alone software product used on the patients’ own smart phone and used in addition to medical treatment. Other Name: NA Device: e-diary All patients (active and control group) participating in the study will report their daily use of ticagrelor in an e-diary which will be initiated on all study patients’ smart phones. |
| Placebo Comparator: The control group In this group the patients will have access to the e-diary only, in which they will report their daily use of ticagrelor. The patients in the control group will not receive any feed-back. | Device: e-diary All patients (active and control group) participating in the study will report their daily use of ticagrelor in an e-diary which will be initiated on all study patients’ smart phones. |
Contacts
Investigators
Principal Investigator
Christoph Varenhorst
Kardiologkliniken, Akademiska Sjukhuset Uppsala
